文献速递流行病学与生物统计临床试验与 GCP

缺血调理对接受侵入性操作者主要临床结局的影响:系统综述与荟萃分析

Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2016-11-07

该系统综述与荟萃分析纳入85篇报告、89项随机对照比较,评估缺血调理对接受侵入性操作者主要临床结局的影响。缺血调理对全因死亡率无影响(风险比0.96,95%CI 0.80-1.16;P=0.68;中等质量证据)。可能降低卒中和急性肾损伤发生率,但证据质量极低至低,且获益似乎仅限于非手术场景和轻度急性肾损伤。

要点

  • 缺血调理对全因死亡率无影响(风险比0.96,95%CI 0.80-1.16;P=0.68;中等质量证据)。
  • 可能降低卒中(风险比0.72,95%CI 0.52-1.00;P=0.048;极低质量证据)和急性肾损伤(风险比0.83,95%CI 0.71-0.97;P=0.02;低质量证据)发生率。
  • 作者结论:除非进一步高质量、把握度充分证据显示获益,否则不推荐常规采用缺血调理。

核心结论

  • 缺血调理对死亡风险无总体影响。
  • 鉴于方法学问题和低事件率,对卒中和急性肾损伤的可能影响不确定。
  • 除非进一步高质量且把握度充分证据显示获益,否则不能推荐常规采用缺血调理。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline、Embase、Cochrane数据库和国际临床试验注册平台,自建库至2015年10月。
  • 纳入所有比较缺血调理对临床结局影响的随机对照研究。
  • 共纳入85篇报告、89项随机对照比较,参与者中位数80例(四分位距60-149),预期持续时间中位数1个月(范围1天至72个月)。
  • 两名作者独立提取数据,多干预组报告视为独立试验;采用随机效应模型计算汇总估计。

主要发现

  • 缺血调理对全因死亡率无影响(68项比较;424例事件;11619例参与者;风险比0.96,95%CI 0.80-1.16;P=0.68;中等质量证据),与临床场景或干预相关特征无关。
  • 缺血调理可能降低卒中发生率(18项试验;5995例参与者;149例事件;风险比0.72,95%CI 0.52-1.00;P=0.048;极低质量证据)。
  • 缺血调理可能降低急性肾损伤发生率(36项试验;8493例参与者;1443例事件;风险比0.83,95%CI 0.71-0.97;P=0.02;低质量证据),但获益似乎仅限于非手术场景和轻度急性肾损伤发作。

关键数值与推荐

  • 全因死亡率:风险比0.96,95%CI 0.80-1.16;P=0.68;中等质量证据。
  • 卒中:风险比0.72,95%CI 0.52-1.00;P=0.048;极低质量证据。
  • 急性肾损伤:风险比0.83,95%CI 0.71-0.97;P=0.02;低质量证据。

临床怎么用

  • 作者结论指出,除非进一步高质量且把握度充分证据显示获益,否则不能推荐常规采用缺血调理。

局限性

  • 对卒中和急性肾损伤的可能影响因方法学问题和低事件率而不确定。
  • 卒中证据质量极低,急性肾损伤证据质量低。
  • 急性肾损伤的获益似乎仅限于非手术场景和轻度发作。
  • 作者结论指出需要进一步高质量且把握度充分的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To summarise the benefits and harms of ischaemic conditioning on major clinical outcomes in various settings. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, Embase, Cochrane databases, and International Clinical Trials Registry platform from inception through October 2015. STUDY SELECTION: All randomised controlled comparisons of the effect of ischaemic conditioning on clinical outcomes were included. DATA EXTRACTION: Two authors independently extracted data from individual reports. Reports of multiple intervention arms were treated as separate trials. Random effects models were used to calculate summary estimates for all cause mortality and other pre-specified clinical outcomes. All cause mortality and secondary outcomes with P<0.1 were examined for study quality by using the GRADE assessment tool, the effect of pre-specified characteristics by using meta-regression and Cochran C test, and trial sequential analysis by using the Copenhagen Trial Unit method. RESULTS: 85 reports of 89 randomised comparisons were identified, with a median 80 (interquartile range 60-149) participants and median 1 (range 1 day-72 months) month intended duration. Ischaemic conditioning had no effect on all cause mortality (68 comparisons; 424 events; 11 619 participants; risk ratio 0.96, 95% confidence interval 0.80 to 1.16; P=0.68; moderate quality evidence) regardless of the clinical setting in which it was used or the particular intervention related characteristics. Ischaemic conditioning may reduce the rates of some secondary outcomes including stroke (18 trials; 5995 participants; 149 events; risk ratio 0.72, 0.52 to 1.00; P=0.048; very low quality evidence) and acute kidney injury (36 trials; 8493 participants; 1443 events; risk ratio 0.83, 0.71 to 0.97; P=0.02; low quality evidence), although the benefits seem to be confined to non-surgical settings and to mild episodes of acute kidney injury only. CONCLUSIONS: Ischaemic conditioning has no overall effect on the risk of death. Possible effects on stroke and acute kidney injury are uncertain given methodological concerns and low event rates. Adoption of ischaemic conditioning cannot be recommended for routine use unless further high quality and well powered evidence shows benefit.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Sukkar L, Hong D, Wong MG, et al. Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis. BMJ. 2016. PMID: 27821641. doi:10.1136/bmj.i5599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。